USPTO serial 79330088
S SCITARIS BIOPHARMA STRATEGY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 2, 2022
- Examiner
- LAMONT, JOHN CHRISTOPHER
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with S SCITARIS BIOPHARMA STRATEGY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Frank D Taff
Frank D Taff FRANK D. TAFF, J.D.3601 SW 29th StreetSuite 109Topeka, KS 66614Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Advertising; business management; business administration | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design in the field of pharmaceuticals; medical device design services; product development; pharmaceutical research and development; pharmaceutical product evaluation; consultancy relating to pharmaceutical research and development; consultancy in the field of pharmaceutical research; medical and pharmacological research services; quality control for others in the field of pharmaeeuticals; authentication services being inspection of pharmaceuticals | ACTIVE | — |
| 044 | Medical services; pharmacy advice; medical consultancy and information services relating to medical products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Scitaris GmbH
- Other trademarks owned by Scitaris GmbH & Co. KG
- Other trademarks owned by Scitaris GmbH
- Other trademarks owned by Scitaris GmbH
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named S SCITARIS BIOPHARMA STRATEGY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 7, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Mar 12, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 5, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 10, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 10, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 2, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 2, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 2, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 17, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 17, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 16, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 27, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 27, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 27, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 18, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 14, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 13, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 13, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 13, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 13, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 2, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 1, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 1, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 28, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 28, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 26, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 25, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 8, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 4, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 30, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |